These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 17079049)

  • 21. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapidly disintegrating oramucosal drug delivery technologies.
    Reddy D; Pillay V; Choonara YE; du Toit LC
    Pharm Dev Technol; 2009; 14(6):588-601. PubMed ID: 19883248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R; Müller RH
    Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular implants for extended drug delivery: therapeutic applications.
    Bourges JL; Bloquel C; Thomas A; Froussart F; Bochot A; Azan F; Gurny R; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1182-202. PubMed ID: 17107737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular application of chitosan.
    Başaran E; Yazan Y
    Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rise and rise of drug delivery.
    Rosen H; Abribat T
    Nat Rev Drug Discov; 2005 May; 4(5):381-5. PubMed ID: 15864267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of novel drug delivery system for herbal formulations.
    Ajazuddin ; Saraf S
    Fitoterapia; 2010 Oct; 81(7):680-9. PubMed ID: 20471457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
    Cone EJ
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S31-9. PubMed ID: 16458455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of prebiotics in oral delivery of bioactive compounds: a nanotechnology perspective.
    Heidarpour F; Mohammadabadi MR; Zaidul IS; Maherani B; Saari N; Hamid AA; Abas F; Manap MY; Mozafari MR
    Pharmazie; 2011 May; 66(5):319-24. PubMed ID: 21699064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive features of "chronotherapeutic" and "pulsatile" drug delivery systems negating the practice of their interchangeable terminology.
    Ali J; Baboota S; Ahuja A; Saigal N
    J Drug Target; 2010 Jul; 18(6):413-9. PubMed ID: 20132094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polymeric nanoparticles: new systems for improving ocular bioavailability of drugs].
    Alonso MJ
    Arch Soc Esp Oftalmol; 2001 Aug; 76(8):453-4. PubMed ID: 11484135
    [No Abstract]   [Full Text] [Related]  

  • 36. Commercial challenges of protein drug delivery.
    Brown LR
    Expert Opin Drug Deliv; 2005 Jan; 2(1):29-42. PubMed ID: 16296733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
    Ranta VP; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the drug selection and development process for combination devices.
    Hupcey MA; Ekins S
    Drug Discov Today; 2007 Oct; 12(19-20):844-52. PubMed ID: 17933686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanosuspensions: a promising drug delivery strategy.
    Patravale VB; Date AA; Kulkarni RM
    J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.